FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations (Q35000851)

5 August 2017

1 reference

title

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations (English)

1 reference

5 August 2017

1 reference

Koji Murakami

1

1 reference

5 August 2017

publication date

1 May 2011

1 reference

World journal of clinical oncology

5 August 2017

published in

1 reference

5 August 2017

volume

2

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

229-236

1 reference

Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Usefulness of 18 F-FDG PET in intrahepatic cholangiocarcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Additional value of FDG-PET/CT in management of "solitary" liver metastases: preliminary results of a prospective multicenter study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine‐18‐labeled fluoro‐deoxyglucose (FDG‐PET)

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100499

Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer

26 October 2018

1 reference

12 December 2020

FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease

1 reference

12 December 2020

PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT

1 reference

12 December 2020

Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection

1 reference

12 December 2020

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET

1 reference

12 December 2020

Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography

1 reference

12 December 2020

Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.5306/WJCO.V2.I5.229

1 reference

5 August 2017

1 reference

5 August 2017

1 reference